+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Indian Women Health Diagnostics Market 2019-2025

  • ID: 5124693
  • Report
  • March 2020
  • Region: India
  • Orion Market Research Private Limited

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • Becton, Dickson and Co.
  • F. Hoffmann-La Roche Ltd.
  • Fujifilm Holdings Corp.
  • General Electric Co.
  • Koninklijke Philips N.V.
Indian Women Health Diagnostics Market Size, Share & Trends Analysis Report by Application (Breast Cancer Testing, Cervical Cancer Testing, Pregnancy & Fertility Testing, Ovarian Cancer Testing, Infectious Disease Testing, Ultrasound Tests, Sexually Transmitted Disease Testing, and Others (Osteoporosis Testing and Prenatal Genetic Testing)), and by End-User (Diagnostic and Imaging Centers, Hospitals and Clinics, and Home Care) Forecast Period 2019-2025.

Indian women health diagnostics market is growing at a CAGR of approximately 9.5% during the forecast period. Increasing healthcare infrastructure is estimated to be one of the major factors that are driving the growth of the Indian women health diagnostics market. Over the past few years, a tremendous growth in health sectors in India has been witnessed, along with the increased healthcare spending. Rising incomes and easier access to high quality healthcare facilities and increasing awareness towards health and personal hygiene are estimated to be the major factors that are responsible for improving healthcare infrastructure in India, which augments the Indian women health diagnostics market.

Further, increasing medical tourism in India due to presence of high class healthcare facilities and low cost of treatment, along with the presence of world class hospitals and skilled medical professionals are estimated to be one of the major factors that is contributing significantly towards the growth of the Indian women health diagnostics market.

In addition, cardio-vascular diseases and cancer are the leading causes of fatality in country accounting for around 70-75% of total fatalities. The prevalence of these diseases is showing an upward trend in India and for several reasons this trend is likely to increase. Apart from this, lifestyle changes and changing behavioral patterns are being favorable to the onset of chronic diseases like Diabetes, CVD and others. According to Cancer India, one woman loses its live from cervical cancer every 8 minutes in India, for every 2 women newly diagnosed with breast cancer, one woman dies of it in India, as many as 2,500 persons die every day due to tobacco-related diseases in India, smoking accounts for 1 in 20 fatalities among women. These cancers and diseases can be prevented when screened and detected at an early stage. Thus, increasing the need of screening and diagnosis of such chronic diseases directly augment the Indian women health diagnostic market in the forecast year.

Research Methodology

The market study of the Indian Women Health Diagnostics market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors.

Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

1. Indian Women Health Diagnostics Market Research and Analysis by Application
2. Indian Women Health Diagnostics Market Research and Analysis by End-user

The Report covers:
  • Comprehensive research methodology of the Indian Women Health Diagnostics market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Indian Women Health Diagnostics market.
  • Insights about market determinants which are stimulating the Indian Women Health Diagnostics market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • Becton, Dickson and Co.
  • F. Hoffmann-La Roche Ltd.
  • Fujifilm Holdings Corp.
  • General Electric Co.
  • Koninklijke Philips N.V.
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments

4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities

5. Market Segmentation
5.1. Indian Women Health Diagnostics Market by Applications
5.1.1. Breast Cancer Testing
5.1.2. Cervical Cancer Testing
5.1.3. Pregnancy & Fertility Testing
5.1.4. Ovarian Cancer Testing
5.1.5. Infectious Disease Testing
5.1.6. Ultrasound Tests
5.1.7. Sexually Transmitted Disease Testing
5.1.8. Others (Osteoporosis Testing and Prenatal Genetic Testing)
5.2. Indian Women Health Diagnostics Market by End-User
5.2.1. Diagnostic and Imaging Centers
5.2.2. Hospitals and Clinics
5.2.3. Home Care

6. Company Profiles
6.1. Abbott Laboratories, Inc.
6.2. Becton, Dickson and Co.
6.3. F. Hoffmann-La Roche Ltd.
6.4. Fujifilm Holdings Corp.
6.5. General Electric Co.
6.6. Koninklijke Philips N.V.
6.7. QIAGEN N.V.
6.8. Siemens AG
6.9. Thermo Fisher Scientific Inc.

LIST OF TABLES
1. INDIAN WOMEN HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
2. INDIAN WOMEN HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)

LIST OF FIGURES
1. INDIAN WOMEN HEALTH DIAGNOSTICS MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)
2. INDIAN WOMEN HEALTH DIAGNOSTICS MARKET SHARE BY END-USER, 2018 VS 2025 (%)
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abbott Laboratories, Inc.
  • Becton, Dickson and Co.
  • F. Hoffmann-La Roche Ltd.
  • Fujifilm Holdings Corp.
  • General Electric Co.
  • Koninklijke Philips N.V.
  • QIAGEN N.V.
  • Siemens AG
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown